A phase 1 multiple dose safety and pharmacokinetics study of AIR645, an inhaled IL-4rα 2-MOE GAPMER oligonucleotide Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
Evaluation of treatment with fixed dose combinations in asthma patients in primary care in Sweden by using mannitol challenge test Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Effects of treatment with angiotensin-(1-7) on antigen sensitization of murine experimental model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Three drug regimen in SCLC-ED patients: a phase II study Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial Source: Eur Respir J, 54 (4) 1901030; 10.1183/13993003.01030-2019 Year: 2019
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19 Source: Eur Respir J, 58 (4) 2100673; 10.1183/13993003.00673-2021 Year: 2021
Efficacy, safety and tolerability of 3 day azithromycin (A) versus 10-day conventional treatment (CT) in the treatment of children with acute asthma exacerbation (AE) Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH) Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021
Anti-DP effects on airway bacterial load in a phase 2a trial Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020
BT10+ study design: 10 year follow-up of subjects receiving bronchial thermoplasty (BT) in 3 randomized controlled studies Source: International Congress 2017 – To freeze or heat? Year: 2017
Immunogenicity assessment of intravenous administration of reslizumab in patients with asthma in phase 3 clinical studies Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Changes in the properties of sputum in patients with brochiectasis treated with inhaled manitol for 12 days - A pilot study Source: Annual Congress 2003 - Cellular and molecular mechanisms in epithelium injury and repair Year: 2003
Effect of 5 years of budesonide treatment on growth and adult height in asthmatic children: results from the START study Source: Eur Respir J 2004; 24: Suppl. 48, 211s Year: 2004
Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003
Effect of 2 weeks oral corticosteroids trial on gas exchange in mild stable asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 87s Year: 2003
Effects of distance to treatment centre and case load upon tuberculosis treatment completion Source: Eur Respir J 2011; 38: 1223-1225 Year: 2011
Optimal dosing of specific immunotherapy (SIT) results in persisting long-term effect Source: Eur Respir J 2001; 18: Suppl. 33, 430s Year: 2001
COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing of therapy but was dependent on baseline gas transfer Source: Annual Congress 2008 - Management of COPD Year: 2008
RCT Abstract - Ad26.COV2.S immunogenicity in a Phase 2 trial at different booster dose levels and schedule intervals in adults Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021
Safety, dose finding and efficacy of ectoine inhalation solution in patients with mild asthma Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010